Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page or call 1-877-436-3683.

Steven Rutherford - Principal Scientist - SS, Infectious Diseases

Steven Rutherford

Principal Scientist - SS, Infectious Diseases

"Every day we aim to address difficult but critical research questions and I am constantly inspired by the innovative, rigorous, and collaborative scientific approaches employed by Genentech scientists to seek out answers."
Years at Genentech
Awards & Honors
I joined the Department of Infectious Diseases at Genentech as a Scientist in 2013. My background is in bacterial physiology and genetics and my group focusses on discovering and validating novel antibiotic targets in Gram-negative bacteria. I was attracted to Genentech because it offered me the opportunity to investigate difficult scientific questions that are critical for human health and allowed me to work with the most creative, innovative, and collaborative scientists in the world.

Featured Publication

Monoclonal antibody targeting the β-barrel assembly machine of Escherichia coli is bactericidal.

Proc Natl Acad Sci USA 115:3692-3697.

Storek KM, Auerbach MR, Shi H, Garcia NK, Sun D, Nickerson NN, Vij R, Chiang N, Schneider K, Wecksler AT, Skippington E, Nakamura G, Seshasayee D, Koerber JT, Payandeh J, Smith PA, Rutherford ST.